TUBB6

TUBB6 is a β-tubulin isotype that, when incorporated into microtubules, biases them toward dynamic, less-stable behavior, and whose context-inappropriate elevation disorganizes microtubule networks (PMID:30535187, PMID:34869381). Isotype-specific gain- and loss-of-function in skeletal muscle established that chronically elevated TUBB6 — but not TUBB5 — disrupts the ordered microtubule grid, and that TUBB6 is selectively induced during muscle regeneration rather than in mature fibers (PMID:30535187). Live-cell imaging in osteoclasts directly demonstrated this destabilizing activity: loss of TUBB6 slows microtubule growth, prolongs growth lifetime, raises acetylated α-tubulin, and shortens EB1 caps, confirming that TUBB6 promotes dynamic microtubules (PMID:34869381). Through these dynamic microtubules TUBB6 couples to the actin cytoskeleton, controlling podosome belt organization and bone resorption in part by negatively regulating the microtubule association of ARHGAP10, a CDC42 regulator that binds microtubules via its BAR-PH domain (PMID:34869381). In specialized cells, TUBB6 is required for motile cilia axoneme assembly in multiciliated cells (PMID:41074676) and for sprouting angiogenesis, where it is stabilized post-transcriptionally by YBX1 binding its 3' UTR and acts upstream of WNT3A/FZD8 signaling (PMID:40083923). A heterozygous missense mutation (p.Phe394Ser) causes autosomal dominant congenital cranial dysinnervation disorder and compromises microtubule function in a yeast challenge assay (PMID:29016863). In disease contexts, TUBB6 is transcriptionally driven by NFKB1 in glioma and promotes proliferation through Wnt/β-catenin signaling (PMID:40169445), while its post-injury elevation destabilizes microtubules and drives neuroinflammation after intracerebral hemorrhage (PMID:39979490).

1. 2017 Medium

   Established the first human disease link for TUBB6 and provided initial evidence that its mutation impairs microtubule function.

   Evidence co-segregation in a five-generation pedigree plus a yeast benomyl growth assay of the mutant protein

   PMID:29016863

   Open questions at the time

   • Mechanism by which p.Phe394Ser alters microtubule dynamics in human cells not defined
   • No structural model of the mutant tubulin
   • Tissue specificity of the cranial dysinnervation phenotype not mechanistically explained
2. 2019 High

   Resolved whether TUBB6 is functionally distinct from other β-tubulins by showing isotype-specific disruption of ordered microtubule arrays and regeneration-associated induction.

   Evidence reciprocal GFP-tubb6 overexpression and shRNA knockdown versus tubb5 controls in mouse and human muscle fibers, with regeneration-marker correlation

   PMID:30535187

   Open questions at the time

   • Molecular basis for isotype-specific destabilizing activity not identified
   • Whether TUBB6 disorganization is a cause or consequence of dystrophic pathology not separated
   • Upstream regulators of regeneration-associated induction not defined
3. 2021 High

   Directly demonstrated that TUBB6 promotes dynamic microtubules and linked this activity to actin podosome organization and bone resorption.

   Evidence CRISPR/Cas9 KO in osteoclasts with EB1 tracking, acetylated tubulin readout, podosome live imaging, bone resorption assay, and proteomics of microtubule-associated fractions

   PMID:34869381

   Open questions at the time

   • How TUBB6 negatively regulates ARHGAP10-microtubule association mechanistically unresolved at this stage
   • Direct binding partners of TUBB6 not identified
   • Single lab
4. 2025 Medium

   Defined the molecular interface for the TUBB6–ARHGAP10–CDC42 axis by mapping direct microtubule binding to the ARHGAP10 BAR-PH domain.

   Evidence in vitro microtubule binding with BAR domain lysine mutants, osteoclast KO and complementation requiring both microtubule binding and RHO-GTPase regulation (preprint)

   Open questions at the time

   • Preprint, single lab, not peer-reviewed
   • Direct physical contact between TUBB6 and ARHGAP10 versus indirect competition not distinguished
   • Quantitative effect of TUBB6 on ARHGAP10 affinity not measured
5. 2025 High

   Extended TUBB6 function to motile cilia by showing a cell-type-specific requirement for axoneme formation in multiciliated cells.

   Evidence morpholino knockdown in Xenopus with cilia imaging, mRNA in situ hybridization, and axonemal immunolocalization

   PMID:41074676

   Open questions at the time

   • Why mono-motile cilia are spared not explained
   • Whether human TUBB6 has the same ciliary role not tested
   • Molecular role within the axoneme undefined
6. 2025 Medium

   Placed TUBB6 in a post-transcriptional and signaling network controlling sprouting angiogenesis.

   Evidence YBX1-TUBB6 3'UTR RNA binding assay, endothelial TUBB6 KO functional assays, OIR/CNV in vivo models, and transcriptome analysis showing WNT3A/FZD8 dependence

   PMID:40083923

   Open questions at the time

   • How a tubulin isotype controls WNT3A/FZD8 expression mechanistically unclear
   • Direct versus indirect link to Wnt signaling not separated
   • Single lab
7. 2025 Medium

   Connected TUBB6 transcriptional control to cancer by identifying NFKB1-driven expression and Wnt/β-catenin-dependent proliferation in glioma.

   Evidence promoter binding/ChIP-type analysis, NFKB1 and TUBB6 knockdown with proliferation, apoptosis, and Wnt/β-catenin pathway readouts in glioma cell lines

   PMID:40169445

   Open questions at the time

   • Whether Wnt/β-catenin regulation is direct or via microtubule dynamics not resolved
   • In vivo tumor relevance not tested
   • Single lab
8. 2025 Medium

   Demonstrated a pathogenic role for elevated TUBB6 in CNS injury through microtubule destabilization and neuroinflammation.

   Evidence antisense oligonucleotide inhibition in a rat intracerebral hemorrhage model with acetylated α-tubulin, MAPK, cytokine, neurodegeneration, and behavioral readouts

   PMID:39979490

   Open questions at the time

   • No in vitro mechanistic validation linking TUBB6 to MAPK signaling
   • Cell type driving the effect not defined
   • Single lab

• The biophysical basis by which the TUBB6 isotype confers microtubule instability, and the direct molecular partners that translate this into actin, ciliary, Wnt, and inflammatory outputs, remain unresolved.
• No structural explanation for isotype-specific destabilization
• No reconstituted system relating TUBB6 incorporation to dynamics quantitatively
• Whether the diverse cell-type phenotypes share one molecular mechanism unknown